SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-23-000067
Filing Date
2023-09-06
Accepted
2023-09-06 17:09:17
Documents
12
Period of Report
2023-09-05
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K flks-20230905.htm   iXBRL 8-K 26617
  Complete submission text file 0001615219-23-000067.txt   151776

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20230905.xsd EX-101.SCH 1926
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20230905_lab.xml EX-101.LAB 23894
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20230905_pre.xml EX-101.PRE 12543
6 EXTRACTED XBRL INSTANCE DOCUMENT flks-20230905_htm.xml XML 2724
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 231240045
SIC: 2834 Pharmaceutical Preparations